In a pre-launch clinical evaluation collecting postoperative clinical outcomes, RayOne Galaxy (n=52 eyes) showed a trend towards less halo and glare compared to published data on established diffractive IOLs at 1 month post-op.
Galaxy: Amon et al. The Ophthalmologist Supplement. 04.2025.
PanOptix: Adapted from Lwowski C et al. J Refract Surg. 2023 Aug;39(8):510-517.